Back
Guggenheim Strategic Opportunities Fund Vs. Hims & Hers Health, Inc. Industry Stock Comparison
Sell
49
GOF
Guggenheim Strategic Opportunities Fund
Last Price:
$12.07
Seasonality Move:
0.63%
Sell
31
HIMS
Hims & Hers Health, Inc.
Last Price:
$35.07
Seasonality Move:
21.52%
Sell
49
Guggenheim Strategic Opportunities Fund (GOF)
is a Sell
Is Guggenheim Strategic Opportunities Fund a Buy, Sell or Hold?
-
The current Guggenheim Strategic Opportunities Fund [GOF] share price is $12.07. The Score for GOF is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
GOF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
31
Hims & Hers Health, Inc. (HIMS)
is a Sell
Is Hims & Hers Health, Inc. a Buy, Sell or Hold?
-
The current Hims & Hers Health, Inc. [HIMS] share price is $34.97. The Score for HIMS is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
HIMS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GOF Stock Price Chart
What is Guggenheim Strategic Opportunities Fund's stock price today?
-
The Guggenheim Strategic Opportunities Fund share price today is $12.07Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GOF is experiencing buying pressure, which is a positive indicator for future bullish movement.
HIMS Stock Price Chart
What is Hims & Hers Health, Inc.'s stock price today?
-
The Hims & Hers Health, Inc. share price today is $34.97Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HIMS is experiencing selling pressure, which indicates risk of future bearish movement.
GOF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.25 | Sell |
| Relative Strength Index (14 RSI): | 34.86 | Sell |
| Chaikin Money Flow: | 931807 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.94 - 12.6) | Sell |
| Bollinger Bands (100): | (12.8 - 15.16) | Sell |
HIMS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.47 | Sell |
| Relative Strength Index (14 RSI): | 37.97 | Sell |
| Chaikin Money Flow: | -10818862 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.6 - 38.88) | Sell |
| Bollinger Bands (100): | (39.24 - 55.52) | Sell |
GOF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.12 | Sell |
| 20-day SMA: | 12.16 | Sell |
| 50-day SMA: | 13.01 | Sell |
| 200-day SMA: | 14.43 | Sell |
| 8-day EMA: | 12.12 | Sell |
| 20-day EMA: | 12.28 | Sell |
| 50-day EMA: | 12.91 | Sell |
| 200-day EMA: | 14.17 | Sell |
HIMS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.49 | Sell |
| 20-day SMA: | 37.36 | Sell |
| 50-day SMA: | 43.06 | Sell |
| 200-day SMA: | 45.8 | Sell |
| 8-day EMA: | 36.94 | Sell |
| 20-day EMA: | 38.03 | Sell |
| 50-day EMA: | 41.67 | Sell |
| 200-day EMA: | 43.4 | Sell |
Guggenheim Strategic Opportunities Fund Earnings Growth & GOF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Hims & Hers Health, Inc. Earnings Growth & HIMS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.12 per share, and an increase next year of $0.16 per share.
Guggenheim Strategic Opportunities Fund Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Hims & Hers Health, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||